ISHARES TR's ticker is IBB and the CUSIP is 464287556. A total of 888 filers reported holding ISHARES TR in Q1 2022. The put-call ratio across all filers is 0.80 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,011,130 | -6.2% | 57,332 | -2.6% | 0.02% | -21.7% |
| Q2 2023 | $7,474,516 | +739.8% | 58,873 | +754.3% | 0.02% | +1050.0% |
| Q1 2023 | $890,042 | -84.7% | 6,891 | -84.4% | 0.00% | -87.5% |
| Q4 2022 | $5,814,440 | +168.7% | 44,287 | +139.4% | 0.02% | +128.6% |
| Q3 2022 | $2,164,000 | -68.4% | 18,500 | -68.3% | 0.01% | -68.2% |
| Q2 2022 | $6,858,000 | +172.7% | 58,300 | +202.1% | 0.02% | +175.0% |
| Q1 2022 | $2,515,000 | -26.2% | 19,300 | -13.7% | 0.01% | -27.3% |
| Q4 2021 | $3,410,000 | -34.9% | 22,351 | -31.0% | 0.01% | -42.1% |
| Q3 2021 | $5,235,000 | +185.8% | 32,374 | +189.1% | 0.02% | +171.4% |
| Q2 2021 | $1,832,000 | +295.7% | 11,200 | +264.1% | 0.01% | +250.0% |
| Q1 2021 | $463,000 | -93.5% | 3,076 | -93.5% | 0.00% | -93.5% |
| Q4 2020 | $7,120,000 | +12.8% | 47,000 | +0.8% | 0.03% | -8.8% |
| Q3 2020 | $6,313,000 | -9.9% | 46,621 | -9.1% | 0.03% | -24.4% |
| Q2 2020 | $7,008,000 | -13.9% | 51,275 | -32.2% | 0.04% | -28.6% |
| Q1 2020 | $8,143,000 | +109.2% | 75,584 | +134.0% | 0.06% | +142.3% |
| Q4 2019 | $3,892,000 | +77.8% | 32,300 | +46.8% | 0.03% | +44.4% |
| Q3 2019 | $2,189,000 | -52.1% | 22,000 | -47.5% | 0.02% | -53.8% |
| Q2 2019 | $4,574,000 | -22.7% | 41,924 | -20.8% | 0.04% | -15.2% |
| Q1 2019 | $5,917,000 | -16.9% | 52,924 | -28.3% | 0.05% | -11.5% |
| Q4 2018 | $7,119,000 | -42.4% | 73,824 | -27.2% | 0.05% | -20.0% |
| Q3 2018 | $12,366,000 | +161.7% | 101,411 | +135.7% | 0.06% | +160.0% |
| Q2 2018 | $4,726,000 | +8.4% | 43,034 | +5.4% | 0.02% | 0.0% |
| Q1 2018 | $4,358,000 | -66.3% | 40,829 | -66.3% | 0.02% | -59.7% |
| Q4 2017 | $12,924,000 | +24.1% | 121,048 | +287.5% | 0.06% | +21.6% |
| Q3 2017 | $10,417,000 | -34.6% | 31,236 | -39.2% | 0.05% | -47.4% |
| Q2 2017 | $15,933,000 | +115.6% | 51,396 | +104.0% | 0.10% | +86.5% |
| Q1 2017 | $7,389,000 | -48.8% | 25,200 | -53.7% | 0.05% | -49.0% |
| Q4 2016 | $14,442,000 | -29.0% | 54,383 | -22.6% | 0.10% | -23.3% |
| Q3 2016 | $20,334,000 | -16.2% | 70,228 | -25.5% | 0.13% | -16.9% |
| Q2 2016 | $24,265,000 | +73.0% | 94,312 | +75.3% | 0.16% | +29.0% |
| Q1 2016 | $14,025,000 | +244.1% | 53,800 | +347.1% | 0.12% | +217.9% |
| Q4 2015 | $4,076,000 | -66.4% | 12,034 | -69.9% | 0.04% | -64.9% |
| Q3 2015 | $12,131,000 | -19.6% | 39,986 | -2.2% | 0.11% | -25.5% |
| Q2 2015 | $15,090,000 | +50.5% | 40,889 | +40.0% | 0.15% | +49.0% |
| Q1 2015 | $10,027,000 | +36.6% | 29,200 | +20.6% | 0.10% | +51.5% |
| Q4 2014 | $7,342,000 | +50.1% | 24,211 | +35.3% | 0.07% | +13.8% |
| Q3 2014 | $4,891,000 | 0.0% | 17,888 | -6.0% | 0.06% | -13.4% |
| Q2 2014 | $4,891,000 | +8.9% | 19,029 | +0.2% | 0.07% | +3.1% |
| Q1 2014 | $4,493,000 | -67.7% | 19,000 | -69.0% | 0.06% | -51.1% |
| Q4 2013 | $13,916,000 | +133.1% | 61,288 | +115.2% | 0.13% | +111.1% |
| Q3 2013 | $5,971,000 | +1041.7% | 28,477 | +846.4% | 0.06% | +1160.0% |
| Q2 2013 | $523,000 | – | 3,009 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atom Investors LP | 78,501 | $10,139,189 | 5.52% |
| Bronte Capital Management Pty Ltd. | 302,076 | $39,016,136 | 4.53% |
| Michelson Medical Research Foundation, Inc. | 43,395 | $5,604,898 | 4.40% |
| Hackensack Meridian Health, Inc. | 228,000 | $29,448,480 | 4.26% |
| DAFNA Capital Management LLC | 102,500 | $13,238,900 | 3.97% |
| Richmond Brothers, Inc. | 16,724 | $2,159,856 | 3.64% |
| Alpha Family Trust | 34,549 | $4,462,349 | 3.53% |
| HANSEATIC MANAGEMENT SERVICES INC | 11,897 | $1,537 | 3.46% |
| PURSUE WEALTH PARTNERS LLC | 37,789 | $4,880,827 | 3.33% |
| Rye Brook Capital LLC | 40,100 | $5,179 | 3.17% |